Leukemia epidemiologist Peter Infante, who originally identified occupational benzene exposure as a leukemia risk in the 1970s, yesterday questioned the decision to remove benzene from the abstract of a 2007 CDC review of childhood leukemia risks published in the U.S. government’s flagship public health journal, Environmental Health Perspectives.
The authors of the review, who work at the U.S. Centers of Disease Control (CDC), asked editors to remove mention of benzene as a childhood leukemia risk from their paper’s abstract and a section of the paper itself, after the paper had been published.
That came as a surprise to NIEHS leukemia researcher James Huff, but NIEHS spokeswoman Christine Bruske Flowers defended the CDC’s request.
“At the time, the data didn’t indicate benzene was a risk factor for childhood leukemia specifically,” Flowers told me. “I think there’s a distinction to be made between saying benzene’s a human carcinogen and saying benzene’s linked to childhood leukemia.”
That explanation didn’t seem to sit well with Infante.
Infante was quick to say the authors were of course free to change their opinion and ask for their paper to be changed.
But he also said the rationale offered by NIEHS’s spokeswoman — that there is or was insufficient evidence tying benzene to childhood leukemia — “doesn’t make sense.”
There are, in fact, studies tying fetal and childhood exposure to benzene, to childhood leukemia risk, he said. Large studies have shown that in-utero exposures to paint, which contains benzene, is a risk factor for childhood leukemia, Infante pointed out.
Moreover, he aruged, there’s no biological basis for assuming children are immune to benzene’s carcinogenicity. Benzene is best established as a risk factor for Acute Myeloid Leukemia (AML), Infante said.
Should we assume a 16 year-old’s AML is less likely sparked by benzene than a 19 year-old’s AML?
“Why would children be any different than adults,” he asked. “Children aren’t a different species. So you have to demonstrate benzene causes AML in children (too)? There are hardly any studies of leukemia in people over 75. Do you have to have evidence it (benzene) specifically causes leukemia in patients in that age group, too?” Read the rest of this entry »